CDC data shows link between myocarditis and COVID vaccines is legitimate, not ‘misinformation’

by Jacob Fuller

Lauren Dempsey, MS in Biomedicine and Law, RN, FISM News 


The federal government and health experts in legacy media circles are once again admitting that something they labeled as “COVID-19 misinformation” and “conspiracy theory” a year ago, is indeed factual.

Data from the Centers for Disease Control and Prevention (CDC) verified that as of Aug. 18 of this year, 2,574 cases of myopericarditis and pericarditis were reported in patients shortly after they received an mRNA vaccine for COVID-19. At least 742 of those cases “met CDC case definition of myocarditis or myopericarditis” in persons under the age of 30.

Myocarditis and pericarditis is a condition that results in inflammation of the heart and the sac covering the heart, respectively, that can lead to sudden death if untreated. Myopericarditis is a combination of the two.

As reports of these serious complications after mRNA vaccination surfaced last year, mainstream media and “fact checkers” widely described concerns as misinformation, parroting the words of “health experts” and government agencies. However, these cases did prompt the CDC’s advisory panel to evaluate reports, leading the FDA to add a warning label to Pfizer-BioNTech and Moderna’s COVID-19 vaccine fact sheets to include the possibility of these heart conditions.

In August, the CDC’s Advisory Committee on Immunization Practices (ACIP) held a meeting about myopericarditis following COVID-19 vaccination. In the meeting, doctors presented data showing 765 reported cases of myopericarditis in patients that occurred within the six days following an mRNA Covid-19 vaccination.

Males accounted for 645 of those cases, with 415 cases found in males aged 12-24. According to the same data set, the expected number of cases of myopericarditis found in males in that age group would normally be no higher than 19, resulting in a staggering 2,084% increase.

For boys aged 12-15 years old, there was a twenty-fold increase in myopericarditis after vaccination, with 117 total cases being reported. Boys aged 16-17 years old were forty times more likely to have myopericarditis, with a total of 121 reported cases. Men aged 18-24 years old had myopericarditis 20 times more than expected with a total of 213 cases.

The updated data on the risk of heart inflammation after mRNA COVID vaccination was released just before another report from the CDC showed that over half of children under 2 years old that were vaccinated experienced a “systemic reaction” after vaccination.

Even with scientific evidence exposing the negative impact that COVID-19 vaccines often have on health, vaccination is still recommended by the CDC for all eligible individuals, including healthy children who are at extremely low risk of having complications from contracting COVID.

The CDC acknowledged in 2021 that there was a connection between cases of heart inflammation and vaccination, but claimed that there was very little reason for concern, citing that in most cases individuals recovered quickly with no long-term symptoms.

Data from the CDC’s monitoring system, Vaccine Safety Datalink (VSD), shows that while the age group most at risk for heart inflammation within the first week after the first vaccination is males between the ages of 12-29, the risk increases for males aged 5-49 after the second dose in the primary series.

Surveillance data also captured incidence rates for myocarditis and pericarditis after the second dose in their primary COVID-19 vaccination series, which showed that there were 14 verified cases out 102,091 males aged 16-17 who got the shot and 31 confirmed cases from the nearly 206,000 12-to-15-year-old males.